The BRCA1ness signature is associated significantly with response to PARP inhibitor treatment versus control in the I-SPY 2 randomized neoadjuvant setting.

by Severson, Tesa M, Wolf, Denise M, Yau, Christina, Peeters, Justine, Wehkam, Diederik, Schouten, Philip C, Chin, Suet-Feung, Majewski, Ian J, Michaut, Magali, Bosma, Astrid, Pereira, Bernard, Bismeijer, Tycho, Wessels, Lodewyk, Caldas, Carlos, Bernards, René, Simon, Iris M, Glas, Annuska M, Linn, Sabine, van 't Veer, Laura
Published 2017

SuperFreq: Integrated mutation detection and clonal tracking in cancer.

by Flensburg, Christoffer, Sargeant, Tobias, Oshlack, Alicia, Majewski, Ian J
Published 2020

BRCA1-like signature in triple negative breast cancer: Molecular and clinical characterization reveals subgroups with therapeutic potential.

by Severson, Tesa M, Peeters, Justine, Majewski, Ian, Michaut, Magali, Bosma, Astrid, Schouten, Philip C, Chin, Suet-Feung, Pereira, Bernard, Goldgraben, Mae A, Bismeijer, Tycho, Kluin, Roelof JC, Muris, Jettie JF, Jirström, Karin, Kerkhoven, Ron M, Wessels, Lodewyk, Caldas, Carlos, Bernards, René, Simon, Iris M, Linn, Sabine
Published 2018

The BRCA1ness signature is associated significantly with response to PARP inhibitor treatment versus control in the I-SPY 2 randomized neoadjuvant setting.

by Severson, Tesa M, Wolf, Denise M, Yau, Christina, Peeters, Justine, Wehkam, Diederik, Schouten, Philip C, Chin, Suet-Feung, Majewski, Ian J, Michaut, Magali, Bosma, Astrid, Pereira, Bernard, Bismeijer, Tycho, Wessels, Lodewyk, Caldas, Carlos, Bernards, René, Simon, Iris M, Glas, Annuska M, Linn, Sabine, van 't Veer, Laura
Published 2017

Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer

by Michaut, Magali, Chin, Suet-Feung, Majewski, Ian, Severson, Tesa M., Bismeijer, Tycho, de Koning, Leanne, Peeters, Justine K., Schouten, Philip C., Rueda, Oscar M., Bosma, Astrid J., Tarrant, Finbarr, Fan, Yue, He, Beilei, Xue, Zheng, Mittempergher, Lorenza, Kluin, Roelof J.C., Heijmans, Jeroen, Snel, Mireille, Pereira, Bernard, Schlicker, Andreas, Provenzano, Elena, Ali, Hamid Raza, Gaber, Alexander, O’Hurley, Gillian, Lehn, Sophie, Muris, Jettie J.F., Wesseling, Jelle, Kay, Elaine, Sammut, Stephen John, Bardwell, Helen A., Barbet, Aurélie S., Bard, Floriane, Lecerf, Caroline, O’Connor, Darran P., Vis, Daniël J., Benes, Cyril H., McDermott, Ultan, Garnett, Mathew J., Simon, Iris M., Jirström, Karin, Dubois, Thierry, Linn, Sabine C., Gallagher, William M., Wessels, Lodewyk F.A., Caldas, Carlos, Bernards, Rene
Published 2016

The BRCA1ness signature is associated significantly with response to PARP inhibitor treatment versus control in the I-SPY 2 randomized neoadjuvant setting.

by Severson, Tesa M, Wolf, Denise M, Yau, Christina, Peeters, Justine, Wehkam, Diederik, Schouten, Philip C, Chin, Suet-Feung, Majewski, Ian J, Michaut, Magali, Bosma, Astrid, Pereira, Bernard, Bismeijer, Tycho, Wessels, Lodewyk, Caldas, Carlos, Bernards, René, Simon, Iris M, Glas, Annuska M, Linn, Sabine, van 't Veer, Laura
Published 2017

The BRCA1ness signature is associatedsignificantly with response to PARP inhibitor treatment versus control in theI-SPY 2 randomized neoadjuvant setting

by Severson, Tesa M. (author), Wolf, Denise M. (author), Yau, Christina (author), Peeters, Justine (author), Wehkam, Diederik (author), Schouten, Philip C. (author), Chin, Suet-Feung (author), Majewski, Ian J. (author), Michaut, Magali (author), Bosma, Astrid (author), Pereira, Bernard (author), Bismeijer, Tycho (author), Wessels, L.F.A. (author), Caldas, Carlos (author), Bernards, Rene (author), Simon, Iris M. (author), Glas, Annuska M. (author), Linn, Sabine C. (author), van 't Veer, Laura (author)
Published 2017